NEPHROPLUSNephrocare Health Services Limited
Healthcare · Medical Care Facilities · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
Why buy
- • Revenue growth: 22.2% YoY
- • Profit growth: 296.2% YoY
- • Debt/Equity: 0.07
- • RSI: 69
- • MACD: bullish
- • Price vs EMA21: above
- • Bollinger Squeeze signal (setup quality 70%)
- • Breakout with Volume signal (setup quality 64%)
Bull case
- • Revenue growth: 22.2% YoY
- • Profit growth: 296.2% YoY
- • Debt/Equity: 0.07
- • RSI: 69
Bear case
- • ROE: 6.9%
- • Valuation vs sector: P/E 90.2 vs sector 52.7
Key risks
- • ROE: 6.9%
- • Valuation vs sector: P/E 90.2 vs sector 52.7
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹27.54). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.